Inhibition of FGFR1 suppressed PCa-bone cell interaction and increased antitumor effects of dovitinib (TK1258), a receptor tyrosine kinase inhibitor that potently inhibited FGFR [84]. This evidence concerns the gene NTRK1 and posterior cortical atrophy.